TNFSF10 and melanoma: When the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene is inserted into the NDV genome, TRAIL binds to death receptors, significantly enhancing NDV’s therapeutic effect against malignant melanoma (25).